Oschner Medical Center

New Orleans, Louisiana 70448

0 studies enrolling now · 9 studies all time

What they study most

Alcoholic Hepatitis (AH), Anemia, Sickle Cell, Antifungal Agents, CNS Tumor, Graft Rejection, Ischemic or Non-ischemic Cardiomyopathy, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Non-left Bundle Branch Block, Parkinson's Disease, Renal Transplantation, Stroke, Ischemic

Studies at this site

• Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry — Completed
• Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations — Running, not enrolling
• STRIDE Biorepository — Status unconfirmed
• COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device — Completed
• CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed
• Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) — Completed
• Screening Anti-Fungal Exposure in Intensive Care Units — Status unconfirmed
• A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection — Completed